John Kilhefner

John Kilhefner

Senior Managing Editor, Lango Franchise

John Kilhefner is Senior Managing Editor of the Luke Lango franchise, which includes Hypergrowth Investing, Innovation Investor, Crypto Investor Network, and more.
Kilhefner has contributed to media such as Benzinga, The Hill, Tip Ranks, Unwinnable, The Arcade Review, Five Out of Ten magazine, and ZAM. He has appeared in U.S. News and World Report, Kotaku, USA Today, and Game Developer.
He now runs his own creative agency focused on tech and cybersecurity, called Skellator, LLC.
Learn more here

Recent Articles

Apple Inc. (AAPL) Stock Is in a World of Hurt

By John Kilhefner, Senior Managing Editor, Lango Franchise

Apple (AAPL) shares have been on the slide every day since the company's fiscal Q4 report. And there's little help in sight for AAPL stock.

Amazon.com, Inc. (AMZN) Is Going to Disrupt Retail Again

By John Kilhefner, Senior Managing Editor, Lango Franchise

AMZN is planning to open 2,000 grocery stores across the U.S, but it will take some time to see if this will boost Amazon stock later on.

Weatherford International Plc (WFT) Stock Gutted After Huge Q3 Loss

By John Kilhefner, Senior Managing Editor, Lango Franchise

Weatherford is taking steps to right the ship, but WFT stock lost 13% today after another rough quarterly earnings report.

Juniper Networks, Inc. (JNPR) Stock Bucks Downtrend on Encouraging Guidance

By John Kilhefner, Senior Managing Editor, Lango Franchise

JNPR stock has been through some rough times, but it looks like things are changing. Juniper Networks will likely end the year with a bang.

Freeport-McMoRan Inc (FCX) Stock Finally Gets Some Earnings Help

By John Kilhefner, Senior Managing Editor, Lango Franchise

FCX stock is up on the news that it has posted its first profit in seven quarters. However, debt remains an issue for Freeport-McMoRan.

PTC Therapeutics, Inc. (PTCT) Stock Tanks 30% After FDA Denies Its Appeal

By John Kilhefner, Senior Managing Editor, Lango Franchise

PTCT stock suffered a heavy blow today, which came after the FDA denied PTC Therapeutics' appeal concerning its muscular dystrophy drug.

Chipotle Mexican Grill, Inc. (CMG) Stock Drops 3% on Continued Pessimism

By John Kilhefner, Senior Managing Editor, Lango Franchise

Chipotle stock is down again after a report suggested CMG still has a ways to go to get on its feet. Here's what you need to know.

Supernus Pharmaceuticals Inc (SUPN) Stock Dips Despite Positive ADHD Data

By John Kilhefner, Senior Managing Editor, Lango Franchise

Supernus Pharmaceuticals Inc (SUPN) was up as much as 2% before giving up its gains, despite posting positive top-line data for its ADHD drug. Here's why.

Boeing Co (BA) Lands $18.6B Deal With Qatar Airways

By John Kilhefner, Senior Managing Editor, Lango Franchise

Boeing Co (NYSE:BA) just delivered a huge blow to Airbus by agreeing to an $18.6 billion deal with Qatar Airways.

Tesaro Inc (TSRO) Soars on Trial Data, Analyst Upgrades

By John Kilhefner, Senior Managing Editor, Lango Franchise

Tesaro Inc (NASDAQ:TSRO) is up 18% after posting positive data in its Nova trial for treating ovarian cancer. Analysts are beside themselves.

Load More